Johnson & Johnson (JNJ) Financials

$266.17

$-4.39 (-1.62%)

As on 03-Nov-2026 16:25EST

Market cap

$662,492 Mln

Revenue (TTM)

$99,335 Mln

P/E Ratio

41.8

P/B Ratio

Div. Yield

2 %

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Operating Revenue	99,335.00	94,193.00	88,821.00	85,159.00	79,990.00	78,740.00
Cost of Revenue	30,982.00	30,256.00	27,471.00	26,739.00	24,596.00	23,402.00
Gross Profit	68,353.00	63,937.00	61,350.00	58,413.00	55,394.00	55,338.00
Operating Expenses	42,828.00	38,341.00	66,672.00	36,560.00	34,381.00	34,395.00
Operating Profit (EBIT)	25,525.00	25,596.00	22,149.00	21,853.00	21,013.00	20,943.00
Other Income	--	--	--	--	-1,381.00	-436.00
Profit before Tax	17,737.00	32,581.00	16,687.00	15,062.00	19,359.00	19,178.00
Provision for Tax	1,642.00	5,777.00	2,621.00	1,736.00	2,989.00	1,377.00
Profit after Tax (Net Income)	16,095.00	26,804.00	14,066.00	35,153.00	17,941.00	20,878.00
Minority Interest	--	--	--	--	--	--
Consolidated Profit	5,116.00	26,804.00	14,066.00	35,153.00	17,941.00	20,878.00

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Shareholder's Funds	81,529.00	81,544.00	71,490.00	68,774.00	76,804.00	74,023.00
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	60,439.00	63,540.00	58,293.00	52,502.00	54,772.00	62,769.00
Current Liabilities	55,457.00	54,126.00	50,321.00	46,282.00	55,802.00	45,226.00
Total Liabilities	252,882.00	199,210.00	180,104.00	167,558.00	187,378.00	182,018.00

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Non-Current Assets	141,074.00	143,586.00	124,211.00	114,063.00	132,084.00	121,039.00
Current Assets	56,351.00	55,624.00	55,893.00	53,495.00	55,294.00	60,979.00
Total Assets	252,882.00	199,210.00	180,104.00	167,558.00	187,378.00	182,018.00
Total Debt*	44,651.00	47,933.00	36,634.00	29,332.00	39,642.00	33,751.00
Net Current Assets	894.00	1,498.00	5,572.00	7,213.00	-508.00	15,753.00

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Cash From Operating Activities	--	24,530.00	24,266.00	22,791.00	21,194.00	23,410.00
Cash Flow from Investing Activities	--	-23,588.00	-18,599.00	878.00	-12,371.00	-8,683.00
Cash from Financing Activities	--	-5,539.00	-3,132.00	-15,825.00	-8,871.00	-14,047.00
Net Cash Inflow / Outflow	--	--	--	--	-48.00	680.00

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Adjusted EPS ($)	6.59	10.99	5.80	14.46	6.73	7.82
Cash EPS ($)	--	14.07	8.82	17.54	9.35	10.59
Adjusted Book Value ($)	--	33.43	29.45	28.29	28.83	27.72
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	10.06	10.00	9.38	7.96	8.77
Free Cash Flow per Share ($)	--	8.08	8.18	7.51	6.45	7.40

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
ROCE (%)	--	22.56	13.64	32.77	16.00	20.24
ROE (%)	19.78	35.03	20.06	48.29	23.79	30.41
ROA (%)	6.48	14.13	8.09	19.81	9.71	11.70
EBIT Margin (%)	18.85	35.62	19.64	25.66	24.55	24.59
Net Margin (%)	16.20	28.46	15.84	41.28	22.82	26.66
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Revenue Growth (%)	7.80	0.06	0.04	0.06	0.02	-0.05
EBIT Growth (%)	-41.80	92.36	-20.18	11.30	1.42	15.95
Net Profit Growth (%)	-35.92	90.56	-59.99	95.94	-14.07	41.89
EPS Growth (%)	-36.38	0.90	-0.60	1.15	-0.14	0.42
Book Value Growth (%)	2.00	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Price / Earnings	41.76	18.83	24.95	10.84	26.23	21.88
Price / Book Value	8.00	6.19	4.91	5.54	6.13	6.17
Dividend Yield (%)	1.95	--	--	--	--	--
EV/EBITDA	25.36	12.97	14.65	13.20	18.34	17.16
Close Price ($)	264.74	206.95	144.62	156.74	176.65	171.07
High Price ($)	281.07	215.19	168.85	180.93	186.69	179.92
Low Price ($)	182.94	140.68	142.75	144.95	155.72	151.47
Market Cap ($ Cr)	662,491.82	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Debt to Equity	0.44	0.59	0.51	0.43	0.52	0.46
Short term debt to equity ratio	0.11	0.10	0.08	0.05	0.17	0.05
Current Ratio	1.02	1.03	1.11	1.16	0.99	1.35
Quick Ratio	0.74	0.77	0.86	0.91	0.81	1.12
Interest Coverage	23.23	34.55	23.10	17.52	71.14	105.80

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Debtors to sales (%)	19.11	18.24	21.31	17.46	21.15	24.11
Asset Turnover	0.40	0.50	0.51	0.48	0.43	0.44
Receivable days	--	70.00	69.50	68.17	81.96	75.52
Inventory Days	--	160.77	157.06	146.49	153.36	153.98
Payable days	--	134.61	132.58	133.33	155.51	160.45
Cash Conversion Cycle	--	96.16	93.97	81.34	79.82	69.05

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Income Statement ($ Mln)